Home / Life Sciences

Legal News

FDA introduces its Cybersecurity Modernization Action Plan

Copyright © 2025 LexisNexis

Published on: 18 November 2022

Published by LNB News

LNB News 18/11/2022

Document Information

Issue Date: 18 November 2022

Published Date: 18 November 2022

Jurisdiction(s): United Kingdom

Article summary

The US Food and Drug Administration (FDA) has introduced its Cybersecurity Modernization Action Plan (CMAP) as part of the next phase of the its enterprise digital approach. The action plan outlines measures the FDA will take to modernise its cybersecurity and cyber defences to meet current and future cybersecurity needs. It also outlines the steps the FDA will take to achieve its Zero Trust model. The aim of this model is to ensure that the right people have the right accesses to the right resources at the right time.

Popular documents

Late payment penalties—inheritance tax

Late payment penalties—inheritance taxWhile interest often accrues on overdue tax, the late payment of certain taxes may also attract a penalty. For information on the interest accruing on overdue tax, see Practice Notes: IHT—payment deadlines on death—Interest on IHT and Interest on late paid

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of